Temporal Trends in Complex Percutaneous Coronary Interventions

Abstract

BackgroundAccumulated experience combined with technological advancements in percutaneous coronary interventions (PCI) over the past four decades, has led to a gradual increase in PCI utilization and complexity. We aimed to investigate the temporal trends in PCI complexity and the outcomes of complex PCI (C-PCI) in our institution.MethodsWe analyzed 20,301 consecutive PCI procedures performed over a 12-year period. C-PCI was defined as a procedure involving at least one of the following: Chronic total occlusion (CTO), left main (LM), bifurcation or saphenous vein graft (SVG) PCI. Four periods of 3-year time intervals were defined (2008–10, 2011–2013, 2014–2016, 2017–2019), and temporal trends in the rate and outcomes of C-PCI within these intervals were studied. Endpoints included mortality and major adverse cardiac events [MACE: death, acute myocardial infarction (MI), and target vessel revascularization (TVR)] at 1 year.ResultsA total of 5,647 (27.8%) C-PCI procedures were performed. The rate of C-PCI has risen significantly since 2,017 (31.2%, p < 0.01), driven mainly by bifurcation and LM interventions (p < 0.01). At 1-year, rates of death, acute MI, TVR and MACE, were all significantly higher in the C-PCI group (8.8 vs. 5.1%, 5.6 vs. 4.5%, 5.5 vs. 4.0%, 17.2 vs. 12.2%, p < 0.001 for all, respectively), as compared to the non-complex group. C-PCI preformed in the latter half of the study period (2014–2019) were associated with improved 1-year TVR (4.4% and 4.8% vs. 6.7% and 7.1%, p = 0.01, respectively) and MACE (13.8% and 13.5% vs. 17.3% and 18.2%, p = 0.001, respectively) rates compared to the earlier period (2007–2013). Death rate had not significantly declined with time.ConclusionIn the current cohort, we have detected a temporal increase in PCI complexity coupled with improved 1-year clinical outcomes in C-PCI.

Independent Clinical Impacts of Procedural Complexity on Ischemic and Bleeding Events in Patients with Acute Myocardial Infarction: Long-Term Clinical Study

“…Performance and technologies (e.g., thickness, material, released drugs, etc.) of coronary intervention have improved; however, the proportion of high-risk procedures such as LM PCI or bifurcation PCI has increased over time [ 34 ]. In addition, a domain such as age is a high risk factor for ischemia and, simultaneously, a high risk factor for bleeding.…”

Clinical benefit of long-term use of dual antiplatelet therapy for acute myocardial infarction patients with the PEGASUS-TIMI 54 criteria

“…Moreover, in the case of the DAPT and DES-LATE trials, which are representative studies that showed the effectiveness of the extended DAPT strategy, past 1st generation stents accounted for approximately 40 and 70% ( 2 , 32 ). A recently published paper has shown that the results may differ if a reanalysis is performed by applying this trend ( 33 ). In real-world clinical practice, the risk of high ischemia and high bleeding is high, and the risks increase as the aging society progresses ( 34 ).…”

A multi-center, randomized, double-blinded, parallel, placebo-controlled study to assess the efficacy and safety of Shenqisuxin granule in complex coronary artery disease after PCI: Study protocol

“…Complex coronary artery disease (CCAD), a lesion type with great difficulty and a low success rate in revascularization, is accompanied by a higher rate of major adverse cardiac and cerebrovascular events (MACCE) ( 1 , 2 ). The 10-year mortality rate of three-vessel disease, chronic total occlusion, and left main lesion after percutaneous coronary intervention (PCI) is up to 21, 27.6, and 28%, respectively, much higher than the 18.6% for general lesions ( 3 , 4 ).…”